biotech

Bulls can't build as headlines start to matter more.
This portfolio is designed to produce a blended yield of 6% to 8%.
Despite a long list of negatives, the ursine class has been unable to push the market into a full-blown downtrend.
This is one of those days when it may pay to walk away.
Biotechnology is showing little relative strength and oil is up again, but there isn't much going on with themes.
This is not the time or the market for such a swarm.
But it is not without some pain.
Great traders will bide their time in this environment and then move big and fast when the conditions are right.
Their overseas business has been carrying them.
The refusal to gap down at the open was probably a short-term negative.

Columnist Conversations

Wendy's is extending last week's rally with another 2% of upside.  The stock is working on a 6 day winnin...
We have a nice win here, but want to stay on the name. SOLD HLF MAY 57.5 CALL AT 5 (in at 3.30) BOUGHT H...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.